| Officer | In this role | Source |
|---|---|---|
|
James A. Helliwell
Also a director
Chief Executive Officer and Director
|
Not stated | |
|
Alex Rothwell
Chief Financial Officer
|
Since 2025
1 year
|
|
|
Amanda Malone
Chief Scientific Officer
|
Since 2012
14 years
|
|
|
Paul Brennan
Chief Business Officer
|
Since 2022
4 years
|
|
|
Mark Kowalski
Chief Medical Officer
|
Since 2023
3 years
|
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Related-party transactions come from the company’s proxy statement. EUPRAXIA PHARMACEUTICALS INC. has not filed one with the SEC.
Loading...